Urine proteomics as a new diagnostic approach for cardiovascular risk and as a discovery tool for novel pathomechanisms in atherosclerotic disease

尿液蛋白质组学作为心血管风险的新诊断方法和动脉粥样硬化疾病新病理机制的发现工具

• 批准号: nhmrc : 1056147
• 负责人: Dr Nay Htun
• 金额: $ 4.63万
• 依托单位: Baker IDI Heart and Diabetes Institute
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/urine-proteomics-new-atherosclerotic-disease/112529
• 关键词: Urine; proteomics; new; diagnostic; approach

Atherosclerosis (hardening of blood vessels) followed by blockage is the leading cause of death due to heart attacks and strokes. Up until now there has been no simple tests to predict this reliably.The outcome of this project will give us a better understanding of atherosclerosis and provide a simple non-invasive urine test to detect atherosclerosis which would lend clinicians the opportunity to intervene early.

动脉粥样硬化（血管硬化）和随后的阻塞是心脏病发作和中风导致死亡的主要原因。到目前为止，还没有简单的测试可以可靠地预测这一点。该项目的结果将使我们更好地了解动脉粥样硬化，并提供一种简单的非侵入性尿液测试来检测动脉粥样硬化，这将为临床医生提供早期干预的机会。